Pseudoneutropenia in lymphangioleiomyomatosis (LAM) patients receiving sirolimus: evaluation in a 100 patient cohort

• Vissagan Gopalakrishnan,
• Amanda M. Jones,
• Patricia Julien-Williams,
• Tania Machado,
• Robert L. Danner,
• Jeffrey J. Swigris,
• Robert Paine,
• Jay N. Lozier,
• Joel Moss

Affiliations

Vissagan Gopalakrishnan

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

Amanda M. Jones

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

Patricia Julien-Williams

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

Tania Machado

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA

Robert L. Danner

Critical Care Medicine Dept, NIH Clinical Center, Bethesda, MD, USA

Jeffrey J. Swigris

Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA

Robert Paine

Division of Respiratory, Critical Care and Occupational Pulmonary Medicine, Dept of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, USA

Jay N. Lozier

Dept of Laboratory Medicine, NIH Clinical Center, Bethesda, MD, USA

Joel Moss

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA